HER2-expressing Non-small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch HER2-expressing Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers (NCT05091528) | Silverback Therapeutics | 2022-02-08 |
Track HER2-expressing Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.